Triphala and Gut Motility on a GLP-1: What the Research Shows

The short answer: Triphala is a traditional Ayurvedic blend of three fruits — amla, haritaki, and bibhitaki — with centuries of traditional use for digestion, and a growing body of modern research on gut motility and the microbiome. The anthraquinones in haritaki support peristalsis in a way plain fiber can't, and a 2025 microbiota study found real, if mixed, effects on the gut ecosystem. The honest caveat: rigorous, large-scale clinical trials specifically on triphala remain limited, so some of what's written about it outruns the evidence.

What triphala actually is

Triphala combines amalaki (Emblica officinalis), haritaki (Terminalia chebula), and bibhitaki (Terminalia bellirica) — three fruits used together in Ayurvedic medicine for digestive support, among other traditional uses.¹ The formula is rich in polyphenols and contains gallic, chebulagic, and chebulinic acids, which research has linked to antioxidant and cytoprotective effects, separate from its role in motility.¹

What the research says about motility specifically

The mechanism most directly tied to motility comes from haritaki's anthraquinone content — the same broad class of plant compounds found in other traditional stimulant-laxative botanicals, which trigger contraction in the intestinal muscle wall. A review on triphala's applications in functional gastrointestinal disorders describes this as a likely bidirectional effect depending on the gut's starting state — supporting peristalsis where it's sluggish, without the same all-or-nothing effect of a harsh stimulant laxative used daily.¹ That bidirectional, adaptive quality is part of why triphala is traditionally used gently and consistently rather than as an occasional harsh laxative.

What the research says about the gut microbiome

A 2025 study modeling triphala's effect in a simulated constipated human colon found a mixed picture worth being upfront about: triphala increased the beneficial bacterium Akkermansia muciniphila and reduced several fermentation byproducts (ammonia, valeric, isovaleric, and isobutyric acids) associated with poor gut health — but it also reduced levels of bifidobacteria, another generally beneficial group.² A separate double-blind, randomized, placebo-controlled pilot study on triphala (alongside manjistha) also found measurable shifts in gut microbiota composition.³ The takeaway isn't "triphala is uniformly good for the microbiome" — it's that triphala measurably changes the gut microbial ecosystem, with effects that go in more than one direction.

Where the evidence is thinner than the marketing

A lot of what's written online about triphala cites large, precise-sounding trial results that are difficult to trace back to an actual published study. To be direct about it: large-scale, rigorously controlled human trials on triphala specifically for constipation are still limited. What exists is a combination of long traditional use, plausible and partially-confirmed mechanisms (the anthraquinone and polyphenol content), and smaller modern studies — not the depth of RCT evidence that exists for something like psyllium. That doesn't mean triphala doesn't work; it means the confident, specific statistics you'll see on some wellness sites are outrunning what's actually been published.

Why it's still the third lever in our protocol

Fiber addresses bulk. Magnesium addresses water content. Neither directly addresses motility — the muscular movement that's specifically slowed by GLP-1 medications. Triphala is the ingredient in the routine that's traditionally used and mechanistically plausible for that piece, which is why it's the third lever rather than a fourth fiber source or a second magnesium. I cover how the three work together in how I'd walk a patient through staying regular on a GLP-1.

Frequently asked questions

Is triphala safe to take every day? It's traditionally used as a daily, gentle support rather than an occasional harsh laxative, but talk to your provider before daily use, especially alongside other medications.

Why does triphala reduce some beneficial bacteria if it's supposed to help gut health? The 2025 microbiota research found a mixed effect — increases in some beneficial markers, decreases in others. This is a reminder that "supports the microbiome" is more complicated in practice than it sounds on a label, for triphala or any other ingredient.

Is triphala the same as a stimulant laxative? Not exactly. It contains anthraquinones, the same broad compound class found in stimulant laxatives, but traditional and research use frames it as a gentler, adaptive support rather than a harsh one-time stimulant — still worth using thoughtfully rather than as a daily crutch at a high dose.

Should I trust specific statistics I see about triphala online? Be cautious with anything citing very precise numbers without a traceable source. Some of what circulates about triphala on wellness sites doesn't lead back to a real, findable study.

Sources

1. Peterson CT, et al. Triphala: current applications and new perspectives on the treatment of functional gastrointestinal disorders. Chinese Medicine. PMC6052535.
2. Levying evidence of the impact of Triphala in the mildly constipated human colon microbiota. ScienceDirect, 2025. S1756464625000404.
3. Modulatory Effects of Triphala and Manjistha Dietary Supplementation on Human Gut Microbiota: A Double-Blind, Randomized, Placebo-Controlled Pilot Study.